# PSMA PET/CT for Assessment of Recurrent Prostate Cancer

> **NCT02899312** · — · ACTIVE_NOT_RECRUITING · sponsor: **British Columbia Cancer Agency** · enrollment: 2244 (estimated)

## Conditions studied

- Prostatic Neoplasms
- Prostate Cancer

## Interventions

- **DRUG:** PSMA PET/CT scan

## Key facts

- **NCT ID:** NCT02899312
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-03-16
- **Primary completion:** 2027-11
- **Final completion:** 2030-06
- **Target enrollment:** 2244 (ESTIMATED)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02899312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02899312, "PSMA PET/CT for Assessment of Recurrent Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02899312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*